Advertisement

Algal-Oil Capsules and Cooked Salmon: Nutritionally Equivalent Sources of Docosahexaenoic Acid

      Abstract

      Food and nutrition professionals question whether supplement-sourced nutrients appear to be equivalent to those derived from natural food sources. We compared the nutritional availability of docosahexaenoic acid (DHA) from algal-oil capsules to that from assayed cooked salmon in 32 healthy men and women, ages 20 to 65 years, in a randomized, open-label, parallel-group study. In this 2-week study comparing 600 mg DHA/day from algal-oil capsules to that from assayed portions of cooked salmon, mean change from baseline in plasma phospholipids and erythrocyte DHA levels was analyzed and DHA levels were compared by Student's t tests. In post-hoc analyses to determine bioequivalence, least-squares mean ratios of percent change from baseline in plasma phospholipid and erythrocyte DHA levels were compared. DHA levels increased by ∼80% in plasma phospholipids and by ∼25% in erythrocytes in both groups. Changes in DHA levels in plasma phospholipids and erythrocytes were similar between groups. As measured by delivery of DHA to both plasma and erythrocytes, fish and algal-oil capsules were equivalent. Both regimens were generally well-tolerated. These results indicate that algal-oil DHA capsules and cooked salmon appear to be bioequivalent in providing DHA to plasma and red blood cells and, accordingly, that algal-oil DHA capsules represent a safe and convenient source of non–fish-derived DHA.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Academy of Nutrition and Dietetics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • McCann J.C.
        • Ames B.N.
        Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function?.
        Am J Clin Nutr. 2005; 82: 281-295
        • Morale S.E.
        • Hoffman D.R.
        • Castaneda Y.S.
        • Wheaton D.H.
        • Burns R.A.
        • Birch E.E.
        Duration of long-chain polyunsaturated fatty acids availability in the diet and visual acuity.
        Early Hum Dev. 2005; 81: 197-203
        • Fleith M.
        • Clandinin M.T.
        Dietary PUFA for preterm and term infants: Review of clinical studies.
        Crit Rev Food Sci Nutr. 2005; 45: 205-229
        • Birch E.E.
        • Garfield S.
        • Castaneda Y.
        • Hughbanks-Wheaton D.
        • Uauy R.
        • Hoffman D.
        Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula.
        Early Hum Dev. 2007; 83: 279-284
        • Birch E.E.
        • Castaneda Y.S.
        • Wheaton D.H.
        • Birch D.G.
        • Uauy R.
        • Hoffman D.R.
        Visual maturation of term infants fed long-chain polyunsaturated fatty acid-supplemented or control formula for 12 mo.
        Am J Clin Nutr. 2005; 81: 871-879
        • Clandinin M.T.
        • VanAerde J.E.
        • Merkel K.L.
        • Harris C.L.
        • Springer M.A.
        • Hansen J.W.
        • Diersen-Schade D.A.
        Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid.
        J Pediatr. 2005; 146: 461-468
        • Forsyth J.S.
        • Willatts P.
        • Agostoni C.
        • Bissenden J.
        • Casaer P.
        • Boehm G.
        Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood: Follow up of a randomised controlled trial.
        BMJ. 2003; 326: 953
        • Jensen C.L.
        • Voigt R.G.
        • Prager T.C.
        • Zou Y.L.
        • Fraley J.K.
        • Rozelle J.C.
        • Turcich M.R.
        • Llorente A.M.
        • Anderson R.E.
        • Heird W.C.
        Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants.
        Am J Clin Nutr. 2005; 82: 125-132
        • Helland I.B.
        • Smith L.
        • Saarem K.
        • Saugstad O.D.
        • Drevon C.A.
        Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age.
        Pediatrics. 2003; 111: e39-e44
        • Holub D.J.
        • Holub B.J.
        Omega-3 fatty acids from fish oils and cardiovascular disease.
        Mol Cell Biochem. 2004; 263: 217-225
        • Mori T.A.
        • Woodman R.J.
        The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans.
        Curr Opin Clin Nutr Metab Care. 2006; 9: 95-104
        • Maclean C.H.
        • Issa A.M.
        • Newberry S.J.
        • Mojica W.A.
        • Morton S.C.
        • Garland R.H.
        • Hilton L.G.
        • Traina S.B.
        • Shekelle P.G.
        Effects of omega-3 fatty acids on cognitive function with aging, dementia, and neurological diseases.
        Evid Rep Technol Assess (Summ). 2005; 114: 1-3
        • SanGiovanni J.P.
        • Chew E.Y.
        The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina.
        Prog Retin Eye Res. 2005; 24: 87-138
        • Schaefer E.J.
        • Bongard V.
        • Beiser A.S.
        • Lamon-Fava S.
        • Robins S.J.
        • Au R.
        • Tucker K.L.
        • Kyle D.J.
        • Wilson P.W.
        • Wolf P.A.
        Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framingham Heart Study.
        Arch Neurol. 2006; 63: 1545-1550
        • Ervin R.W.J.
        • Wang C.
        • Kennedy-Stephenson J.
        Dietary intake of fats and fatty acids for the United States population: 1999-2000.
        in: Advance Data from Vital and Health Statistics. National Center or Health Statistics, Hyattsville, MD2004: 348 (DHHS Publication No. (PHS) 2005-1250 2004-0565)
        • Wang C.M.
        • Lichtenstein A.
        • Balk E.
        • Kupelnick B.
        • DeVine D.
        • Lawrence A.
        • Lau J.
        Evidence report/technology assessment no. 94. (Prepared by Tufts-New England Medical Center Evidence-Based Practice Center, under contract no. 290-02-0022). Effects of Omega-3 Fatty Acids on Cardiovascular Disease. AHRQ Publication No 04-E009-2.
        Agency for Healthcare Research and Quality, Rockville, MD2004
        • Koletzko B.
        • Cetin I.
        • Brenna J.
        • Perinatal Intake Working Group, Child Health Foundation, Diabetic Pregnancy Study Group, European Association of Perinatal Medicine, European Society for Clinical Nutrition and Metabolism, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Committee on Nutrition; International Federation of Placenta Associations; International Society for the Study of Fatty Acids and Lipids
        Dietary fat intakes for pregnant and lactating women.
        Br J Nutr. 2007; 98: 873-877
        • Simopoulos A.P.
        • Leaf A.
        • Salem Jr, N.
        Workshop statement on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids.
        Prostaglandins Leukot Essent Fatty Acids. 2000; 63: 119-121
        • Kris-Etherton P.M.
        • Harris W.S.
        • Appel L.J.
        Omega-3 fatty acids and cardiovascular disease: New recommendations from the American Heart Association.
        Arterioscler Thromb Vasc Biol. 2003; 23: 151-152
        • American Dietetic Association
        Position of the American Dietetic Association: Fortification and nutritional supplements.
        J Am Diet Assoc. 2005; 105: 1300-1311
        • Agren J.J.
        • Hanninen O.
        • Julkunen A.
        • Fogelholm L.
        • Vidgren H.
        • Schwab U.
        • Pynnonen O.
        • Uusitupa M.
        Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels.
        Eur J Clin Nutr. 1996; 50: 765-771
        • Innis S.M.
        • Hansen J.W.
        Plasma fatty acid responses, metabolic effects, and safety of microalgal and fungal oils rich in arachidonic and docosahexaenoic acids in healthy adults.
        Am J Clin Nutr. 1996; 64: 159-167
        • Makrides M.
        • Neumann M.A.
        • Gibson R.A.
        Effect of maternal docosahexaenoic acid (DHA) supplementation on breast milk composition.
        Eur J Clin Nutr. 1996; 50: 352-357
        • Lloyd-Still J.D.
        • Powers C.A.
        • Hoffman D.R.
        • Boyd-Trull K.
        • Lester L.A.
        • Benisek D.C.
        • Arterburn L.M.
        Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: A randomized, controlled study.
        Nutrition. 2006; 22: 36-46
        • Voigt R.G.
        • Llorente A.M.
        • Jensen C.L.
        • Fraley J.K.
        • Berretta M.C.
        • Heird W.C.
        A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder.
        J Pediatr. 2001; 139: 189-196
        • Birch D.G.
        A randomized placebo-controlled clinical trial of docosahexaenoic acid (DHA) supplementation for X-linked retinitis pigmentosa.
        Retina. 2005; 28: S52-S54
        • Hoffman D.R.
        • Theuer R.C.
        • Castaneda Y.S.
        • Wheaton D.H.
        • Bosworth R.G.
        • O'Connor A.R.
        • Morale S.E.
        • Wiedemann L.E.
        • Birch E.E.
        Maturation of visual acuity is accelerated in breast-fed term infants fed baby food containing DHA-enriched egg yolk.
        J Nutr. 2004; 134: 2307-2313
        • Hoffman D.
        • Birch E.
        • Castaneda Y.
        • Fawcett S.
        • Wheaton D.
        • Birch D.
        • Uauy R.
        Visual function in breast-fed term infants weaned to formula with or without long-chain polyunsaturates at 4 to 6 months: A randomized clinical trial.
        J Pediatr. 2003; 142: 669-677
        • Hoffman D.R.
        • Birch E.E.
        • Castaneda Y.S.
        • Fawcett S.L.
        • Wheaton D.H.
        Post-weaning supply of docosahexaenoic acid (DHA) improves visual maturation in breast-fed term infants.
        FASEB J. 2002; 16: A663
        • Visioli F.
        • Rise P.
        • Barassi M.C.
        • Marangoni F.
        • Galli C.
        Dietary intake of fish vs. formulations leads to higher plasma concentrations of n-3 fatty acids.
        Lipids. 2003; 38: 415-418
        • Benisek D.
        • Bailey-Hall E.
        • Oken H.
        • Masayesva S.
        • Arterburn L.
        Validation of a simple food frequency questionnaire as an indicator of long chain omega-3 intake.
        Inform. 2002; (Abstracts of the 93rd Annual AOCS Meeting and Expo, Montreal, Quebec, Canada): 96S
        • US Food and Drug Administration
        Agency Response Letter GRAS Notice No. GRN 000041.
        US Food and Drug Administration, Department of Health and Human Services, Washington, DC2001 (http://www.cfsan.fda.gov/∼rdb/opa-g041.html. Accessed October 1, 2007)
        • Arterburn L.M.
        • Hall E.B.
        • Oken H.
        Distribution, interconversion, and dose response of n-3 fatty acids in humans.
        Am J Clin Nutr. 2006; 83: 1467S-1476S
        • US Food and Drug Administration
        Guidance for Industry: Statistical Procedures for Bioequivalence Studies Using a Standard Two-Treatment Cross-Over Design.
        US Department of Health and Human Services, Drug Information Branch, Center for Drug Evaluation and Research, Washington, DC1992
        • Maki K.C.
        • Davidson M.H.
        • Dicklin M.R.
        • Ingram K.A.
        • Cyrowski M.
        • Umporowicz D.M.
        • Bell M.
        • Elliott J.G.
        Bioavailability of eicosapentaenoic and docosahexaenoic n-3 polyunsaturated fatty acids in salmon patties compared with capsules.
        J Food Sci. 2000; 68: 761-764
        • Arterburn L.M.
        • Oken H.A.
        • Hoffman J.P.
        • Bailey-Hall E.
        • Chung G.
        • Rom D.
        • Hamersley J.
        • McCarthy D.
        Bioequivalence of docosahexaenoic acid from different algal oils in capsules and in a DHA-fortified food.
        Lipids. 2007; 42: 1011-1024
        • Vidgren H.M.
        • Agren J.J.
        • Schwab U.
        • Rissanen T.
        • Hanninen O.
        • Uusitupa M.I.
        Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men.
        Lipids. 1997; 32: 697-705

      Biography

      L. M. Arterburn is senior director, Pharmacology and Toxicology, Alba Therapeutics, Baltimore, MD; at the time of the study, she was director, Clinical Research, Martek Biosciences Corporation, Columbia, MD.

      Biography

      H. A. Oken is clinical professor of medicine, University of Maryland, Baltimore.

      Biography

      J. A. Hamersley is clinical study coordinator, Charter Medical Group, University of Maryland, Baltimore.

      Biography

      E. Bailey Hall is laboratory manager, Clinical Research, C. N. Kuratko is principal scientist, medical affairs, and J. P. Hoffman is director of medical services, Martek Biosciences Corporation, Columbia, MD.